Induction of Survivin Inhibition, G_2/M Cell Cycle Arrest and Autophagic on Cell Death in Human Malignant Glioblastoma Cells

10.4077/CJP.2015.BAC267

Tswen-Kei Tang；Shih-Che Chiu；Chia-Wen Lin；Mei-Ju Su；May-Hua Liao

Autophagic cell death ； Glioblastoma ； Parthenolide ； Survivin

The Chinese Journal of Physiology

58卷2期（2015 / 04 / 30）

95 - 103

英文

Chemotherapy efficacy is limited by intrinsic and acquired resistance in glioblastoma (GBM); hence, novel tactics are crucial. Survivin has been demonstrated as a key resistant factor in GBM because of its function in inhibiting apoptosis, regulating autophagy, and in promoting G_2/M cell cycle transition. Parthenolide has been reported to be an effective antitumor agent in a variety of tumor cells and decreases survivin level in leukemia cells. But the effect of parthenolide on survivin and the cell death process in GBM is still unknown. The aim of this study was to examine whether parthenolide had the potential to inhibit cell proliferation in the GBM cell line U373. The parthenolide-induced effects in relation to survivin suppression and cell death were further investigated. Our results showed that parthenolide substantially inhibited cell viability with IC_(50) values of approximate 16 μM. Treatment with parthenolide at the dose of 16 μM led to considerable downregulation of survivin, G_2/M cell cycle arrest and Chk2 upregulation in cells. Parthenolide induced apoptosis in only a few cells and a slight increase in activated caspases 3 levels. By contrast, parthenolide induced a significant increase of intracellular autophagosomes and the expression of autophagy related proteins, including ULK1 and LC3 I/LC3 II, in the treated cells. These results suggested that parthenolide induced survivin inhibition, G_2/M cell cycle arrest, and triggered cell death through autophagic cell death in the GBM cell line.

1. Chen, J.H.,Chen, K.Y.,Ma, H.I.,Yu, C.P.,Nieh, S.,Lee, H.S.,Jin, J.S.(2010).Cortactin, fascin and survivin expression associated with clinicopathological parameters in brain gliosarcoma.Chinese J. Physiol.,53,234-244.
   連結：
2. Chen, W.C.,Chou, C.T.,Liou, W.C.,Liu, S.I.,Lin, K.L.,Lu, T.,Lu, Y.C.,Hsu, S.S.,Tsai, J.Y.,Liao, W.C.,Liang, W.Z.,Jan, C.R.(2014).Rise of [Ca2+]i and apoptosis induced by M-3M3FBS in SCM1 human gastric cancer cells.Chinese J. Physiol.,57,31-40.
   連結：
3. Kuo, H.S.,Hsu, F.N.,Chiang, M.C.,You, S.C.,Chen, M.C.,Lo, M.J.,Lin, H.(2009).The role of Cdk5 in retinoic acid-induced apoptosis of cervical cancer cell line.Chinese J. Physiol.,52,23-30.
   連結：
4. Shieh, P.,Tsai, M.L.,Chiu, M.H.,Chen, Y.O.,Yi, N.L.,Jan, C.R.(2010).Independent effects of the broccoli-derived compound sulforaphane on Ca2+ influx and apoptosis in Madin-Darby canine renal tubular cells.Chinese J. Physiol.,53,215-222.
   連結：
5. Abe, A.,Kokuba, H.(2013).Harmol induces autophagy and subsequent apoptosis in U251MG human glioma cells through the downregulation of survivin.Oncol. Rep.,29,1333-1342.
6. Adida, C.,Berrebi, D.,Peuchmaur, M.,Reyes-Mugica, M.,Altieri, D.C.(1998).Anti-apoptosis gene, survivin, and prognosis of neuroblastoma.Lancet,351,882-883.
7. Ambrosini, G.,Adida, C.,Altieri, D.C.(1997).A novel anti-apoptosisgene, survivin, expressed in cancer and lymphoma.Nat. Med.,3,917-921.
8. Bareford, M.D.,Hamed, H.A.,Tang, F.Y.,Cruickshanks, N.,Burow, M.E.,Fisher, P.B.,Moran, R.G.,Nephew, K.P.,Grant, S.,Dent, P.(2011).Sorafenib enhances pemetrexed cytotoxicity through an autophagy-dependent mechanism in cancer cells.Cancer Res.,41,4955-4967.
9. Barth, S.,Glick, D.,Macleod, K.F.(2010).Autophagy: assays and artifacts.J. Pathol.,221,117-124.
10. Beardmore, V.A.,Ahonen, L.J.,Gorbsky, G.J.,Kallio, M.J.(2004).Survivin dynamics increases at centromeres during G2/M phase transition and is regulated by microtubule-attachment and Aurora B kinase activity.J. Cell Sci.,117,4033-4042.
11. Brennan, C.(2011).Genomic profiles of glioma.Curr. Neurol. Neurosci. Rep.,11,291-297.
12. Chakravarti, A.,Noll, E.,Black, P.M.,Finkelstein, D.F.,Finkelstein, D.M.,Dyson, N.J.,Loeffler, J.S.(2002).Quantitatively determined survivin expression levels are of prognostic value in human gliomas.J. Clin. Oncol.,20,1063-1068.
13. Chan, E.Y.,Kir, S.,Tooze, S.A.(2007).siRNA screening of the kinome identifies ULK1 as a multidomain modulator of autophagy.J. Biol. Chem.,282,25464-25474.
14. Chen, C.,Chunyan, J.(2012).Anti-cancer activities of quercetin: mechanisms of apoptosis induction.Adapt. Med.,4,145-154.
15. Cheng, H.H.,Chou, C.T.,Cheng, J.S.,Liang, W.Z.,Chang, H.T.,Kuo, C.C.,Chiang, N.N.,Lan, T.W.,Ho, C.M.,Kuo, D.H.,Shieh, P.,Jan, C.R.(2014).Propanil-induced Ca2+ entry and apoptosis in MDCK canine renal tubular cells.Adapt. Med.,6,21-26.
16. Church, D.N.,Talbot, D.C.(2012).Survivin in solid tumors: rationale for development of inhibitors.Curr. Oncol. Rep.,14,120-128.
17. Curry, E.A., 3rd, Murry, D.J.,Yoder, C.,Fife, K.,Armstrong, V.,Nakshatri, H.,O'Connell, M.,Sweeney, C.J.(2004).Phase I dose escalation trial of feverfew with standardized doses of parthenolide in patients with cancer.Invest. New Drugs,22,299-305.
18. deGraffenried, L.A.,Chandrasekar, B.,Friedrichs, W.E.,Donzis, E.,Silva, J.,Hidalgo, M.,Freeman, J.W.,Weiss, G.R.(2004).NF-κB inhibition markedly enhances sensitivity of resistant breast cancer tumor cells to tamoxifen.Ann. Oncol.,15,885-890.
19. Gammoh, N.,Lam, D.,Puente, C.,Ganley, I.,Marks, P.A.,Jiang, X.(2012).Role of autophagy in histone deacetylase inhibitor-induced apoptotic and nonapoptotic cell death.Proc. Natl. Acad. Sci. USA,109,6561-6565.
20. Ghantous, A.,Sinjab, A.,Herceg, Z.,Darwiche, N.(2013).Parthenolide: from plant shoots to cancer roots.Drug Discov. Today,18,894-905.
21. Guha, M.,Altieri, D.C.(2009).Survivin as a global target of intrinsic tumor suppression networks.Cell Cycle,8,2708-2710.
22. Hehner, S.P.,Hofmann, T.G.,Droge, W.,Schmitz, M.L.(1999).The antiinflammatory sesquiterpene lactone parthenolide inhibits NF-kappa B by targeting the I NF-κB kinase complex.J. Immunol.,163,5617-5623.
23. Hendruschk, S.,Wiedemuth, R.,Aigner, A.,Topfer, K.,Cartellieri, M.,Martin, D.,Kirsch, M.,Ikonomidou, C.,Schackert, G.,Temme, A.(2011).RNA interference targeting survivin exerts antitumoral effects in vitro and in established glioma xenografts in vivo.Neuro. Oncol.,13,1074-1089.
24. Hu, S.J.,Horng, C.T.,Chen, H.I.,Chang, Y.T.,Cheng, C.M.,Liang, W.Z.,Shieh, P.C.,Jan, C.R.(2012).Effect of diethylstilbestrol (DES) on Ca2+ homeostasis and viability in OC2 human oral cancer cells.Adapt. Med.,4,199-208.
25. Hu, Y.C.,Hsieh, B.S.,Cheng, H.L.,Huang, L.W.,Huang, T.C.,Huang, I.Y.,Chang, K.L.(2013).Osteoblasts survive the arsenic trioxide treatment by activation of ATM-mediated pathway.Biochem. Pharmacol.,85,1018-1026.
26. Huo, Q.,Yang, Q.(2013).Role of huaier extract as a promising anticancer drug.Adapt. Med.,4,69-74.
27. Ito, H.,Kanzawa, T.,Miyoshi, T.,Hirohata, S.,Kyo, S.,Iwamaru, A.,Aoki, H.,Kondo, Y.,Kondo, S.(2005).Therapeutic efficacy of PUMA for malignant glioma cells regardless of p53 status.Hum. Gene Ther,16,685-698.
28. Kanzawa, T.,Germano, I.M.,Komata, T.,Ito, H.,Kondo, Y.,Kondo, S.(2004).Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells.Cell Death Differ.,11,448-457.
29. Kanzawa, T.,Kondo, Y.,Ito, H.,Kondo, S.,Germano, I.(2003).Induction of autophagic cell death in malignant glioma cells by arsenic trioxide.Cancer Res.,63,2103-2108.
30. Kappler, M.,Bache, M.,Bartel, F.,Kotzsch, M.,Panian, M.,Wurl, P.,Blumke, K.,Schmidt, H.,Meye, A.,Taubert, H.(2004).Knockdown of survivin expression by small interfering RNA reduces the clonogenic survival of human sarcoma cell lines independently of p53.Cancer Gene Ther.,11,186-193.
31. Kaza, N.,Kohli, L.,Roth, K.A.(2012).Autophagy in brain tumors: a new target for therapeutic intervention.Brain Pathol.,22,89-98.
32. Kim, Y.R.,Eom, J.I.,Kim, S.J.,Jeung, H.K.,Cheong, J.W.,Kim, J.S.,Min, Y.H.(2010).Myeloperoxidase expression as a potential determinant of parthenolide-induced apoptosis in leukemia bulk and leukemia stem cells.J. Pharmacol. Exp. Ther.,335,389-400.
33. Krakstad, C.,Chekenya, M.(2010).Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics.Mol. Cancer,9,135-149.
34. Kuo, P.C.,Liu, H.F.,Chao, J.I.(2004).Survivin and p53 modulate quercetin-induced cell growth inhibition and apoptosis in human lung carcinoma cells.J. Biol. Chem.,279,55875-55885.
35. Lefranc, F.,Sadeghi, N.,Camby, I.,Metens, T.,Dewitte, O.,Kiss, R.(2006).Present and potential future issues in glioblastoma treatment.Expert Rev. Anticancer Ther.,6,719-732.
36. Lim, C.B.,Fu, P.Y.,Ky, N.,Zhu, H.S.,Feng, X.,Li, J.,Srinivasan, K.G.,Hamza, M.S.,Zhao, Y.(2012).NF-κB p65 repression by the sesquiterpene lactone, Helenalin, contributes to the induction of autophagy cell death.BMC Complement Altern. Med.,12,93.
37. Liu, S.I.,Lin, K.L.,Lu, T.,Lu, Y.C.,Hsu, S.S.,Tsai, J.Y.,Liao, W.C.,Huang, F.D.,Chi, C.C.,Liang, W.Z.,Tseng, L.L.,Chiang, A.J.,Jan, C.R.(2013).M-3M3FBS-induced Ca2+ movement and apoptosis in HA59T human hepatoma cells.Chinese J. Physiol.,56,26-35.
38. Liu, W.T.,Lin, C.H.,Hsiao, M.,Gean, P.W.(2011).Minocycline inhibits the growth of glioma by inducing autophagy.Autophagy,7,166-175.
39. Louis, D.N.,Ohgaki, H.,Wiestler, O.D.,Cavenee, W.K.,Burger, P.C.,Jouvet, A.,Scheithauer, B.W.,Kleihues, P.(2007).The 2007 WHO classification of tumours of the central nervous system.Acta Neuropathol.,114,97-109.
40. Mizushima, N.,Yoshimori, T.(2007).How to interpret LC3 immunoblotting.Autophagy,3,542-545.
41. Nakabayashi, H.,Shimizu, K.(2012).Involvement of Akt/NF-κB pathway in antitumor effects of parthenolide on glioblastoma cells in vitro and in vivo.BMC Cancer,12,453.
42. Nakshatri, H.,Rice, S.E.,Bhat-Nakshatri, P.(2004).Antitumor agent parthenolide reverses resistance of breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through sustained activation of c-Jun N-terminal kinase.Oncogene,23,7330-7344.
43. O'Connor, D.S.,Grossman, D.,Plescia, J.,Li, F.,Zhang, H.,Villa, A.,Tognin, S.,Marchisio, P.C.,Altieri, D.C.(2000).Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin.Proc. Natl. Acad. Sci. USA,97,13103-13107.
44. Pozarowski, P.,Halicka, D.H.,Darzynkiewicz, Z.(2003).Cell cycle effects and caspase-dependent and independent death of HL-60 and Jurkat cells treated with the inhibitor of NF-κB parthenolide.Cell Cycle,2,377-383.
45. Prados, M.D.,Chang, S.M.,Butowski, N.,DeBoer, R.,Parvataneni, R.,Carliner, H.,Kabuubi, P.,Ayers-Ringler, J.,Rabbitt, J.,Page, M.,Fedoroff, A.,Sneed, P.K.,Berger, M.S.,McDermott, M.W.,Parsa, A.T.,Vandenberg, S.,James, C.D.,Lamborn, K.R.,Stokoe, D.,Haas-Kogan, D.A.(2009).Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma.J. Clin. Oncol.,27,579-584.
46. Reichert, S.,Rodel, C.,Mirsch, J.,Harter, P.N.,Tomicic, M.T.,Mittelbronn, M.,Kaina, B.,Rodel, F.(2011).Survivin inhibition and DNA double-strand break repair: a molecular mechanism to overcome radioresistance in glioblastoma.Radiother. Oncol.,101,51-58.
47. Riganti, C.,Doublier, S.,Viarisio, D.,Miraglia, E.,Pescarmona, G.,Ghigo, D.,Bosia, A.(2009).Artemisinin induces doxorubicin resistance in human colon cancer cells via calcium-dependent activation of HIF-1alpha and P-glycoprotein overexpression.Brit. J. Pharmacol.,156,1054-1066.
48. Rikiishi, H.(2012).Novel isights into the iterplay between aoptosis and atophagy.Int. J. Cell Biol.,2012,317645-317659.
49. Roca, H.,Varsos, Z.S.,Mizutani, K.,Pienta, K.J.(2008).CCL2, survivin and autophagy: new links with implications in human cancer.Autophagy,4,969-971.
50. Vogelbaum, M.A.,Tong, J.X.,Perugu, R.,Gutmann, D.H.,Rich, K.M.(1999).Overexpression of bax in human glioma cell lines.J. Neurosurg.,91,483-489.
51. Wang, Y.,Ji, P.,Liu, J.,Broaddus, R.R.,Xue, F.,Zhang, W.(2009).Centrosome-associated regulators of the G2/M checkpoint as targets for cancer therapy.Mol. Cancer,8,8-21.
52. Wen, J.,You, K.R.,Lee, S.Y.,Song, C.H.,Kim, D.G.(2002).Oxidative stress-mediated apoptosis. The anticancer effect of the sesquiterpene lactone parthenolide.J. Biol. Chem.,277,38954-38964.
53. Yoshimori, T.(2004).Autophagy: a regulated bulk degradation process inside cells.Biochem. Biophys. Res. Commun.,313,453-458.
54. Yu, M.,Tong, X.,Qi, B.,Qu, H.,Dong, S.,Yu, B.,Zhang, N.,Tang, N.,Wang, L.,Zhang, C.(2013).Berberine enhances chemosensitivity to irinotecan in colon cancer via inhibition of NF-κB.Mol. Med. Rep.,9,249-254.
55. Zanotto-Filho, A.,Braganhol, E.,Battastini, A.M.,Moreira, J.C.(2012).Proteasome inhibitor MG132 induces selective apoptosis in glioblastoma cells through inhibition of PI3K/Akt and NF-κB pathways, mitochondrial dysfunction, and activation of p38-JNK1/2 signaling.Invest. New Drugs,30,2252-2262.
56. Zanotto-Filho, A.,Braganhol, E.,Schroder, R.,de Souza, L.H.,Dalmolin, R.J.,Pasquali, M.A.,Gelain, D.P.,Battastini, A.M.,Moreira, J.C.(2011).NFκB inhibitors induce cell death in glioblastomas.Biochem. Pharmacol.,81,412-424.
57. Zhang, S.,Won, Y.K.,Ong, C.N.,Shen, H.M.(2005).Anti-cancer potential of sesquiterpene lactones: bioactivity and molecular mechanisms.Curr. Med. Chem. Anti-Cancer Agents,5,239-249.
58. Ziegler, D.S.,Wright, R.D.,Kesari, S.,Lemieux, M.E.,Tran, M.A.,Jain, M.,Zawel, L.,Kung, A.L.(2008).Resistance of human glioblastoma multiforme cells to growth factor inhibitors is overcome by blockade of inhibitor of apoptosis proteins.J. Clin. Invest.,118,3109-3122.